أستونيا -
الإستونية -
Ravimiamet
digoxin orifarm 0,25 mg tablett
orifarm healthcare a/s - digoksiin - tablett - 0,25mg 60tk; 0,25mg 50tk
أستونيا -
الإستونية -
Ravimiamet
cataflam kaetud tablett
novartis baltics sia - diklofenak - kaetud tablett - 50mg 20tk
أستونيا -
الإستونية -
Ravimiamet
voltaren retard toimeainet prolongeeritult vabastav tablett
novartis baltics sia - diklofenak - toimeainet prolongeeritult vabastav tablett - 100mg 10tk; 100mg 30tk
أستونيا -
الإستونية -
Ravimiamet
nolvadex d tablett
astrazeneca ab - tamoksifeen - tablett - 20mg 30tk
أستونيا -
الإستونية -
Ravimiamet
lacosamide alembic õhukese polümeerikattega tablett
alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 100mg 14tk; 100mg 168tk; 100mg 56tk; 100mg 28tk
أستونيا -
الإستونية -
Ravimiamet
lacosamide alembic õhukese polümeerikattega tablett
alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 200mg 56tk; 200mg 28tk; 200mg 168tk; 200mg 14tk
أستونيا -
الإستونية -
Ravimiamet
lacosamide alembic õhukese polümeerikattega tablett
alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 50mg 168tk; 50mg 56tk; 50mg 28tk; 50mg 14tk
أستونيا -
الإستونية -
Ravimiamet
lacosamide alembic õhukese polümeerikattega tablett
alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 168tk; 150mg 14tk
أستونيا -
الإستونية -
Ravimiamet
lacosamide fresenius kabi infusioonilahus
fresenius kabi polska sp. z o.o. - lakosamiid - infusioonilahus - 10mg 1ml 20ml 5tk; 10mg 1ml 20ml 10tk; 10mg 1ml 20ml 1tk
الاتحاد الأوروبي -
الإستونية -
EMA (European Medicines Agency)
lacosamide adroiq
extrovis eu ltd. - lakosamiid - epilepsia - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.